Filing Details
- Accession Number:
- 0001209191-11-030787
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-24 19:03:39
- Reporting Period:
- 2011-05-23
- Filing Date:
- 2011-05-24
- Accepted Time:
- 2011-05-24 18:03:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1411861 | Mako Surgical Corp. | MAKO | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 201901148 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1462368 | Ivan Delevic | C/O Mako Surgical Corp. 2555 Davie Road Fort Lauderdale FL 33317 | Svp Strategic Mktg&Bus Develop | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-05-23 | 8,500 | $6.90 | 8,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-05-23 | 8,500 | $31.53 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2011-05-23 | 8,500 | $0.00 | 8,500 | $6.90 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
85,500 | 2019-04-27 | No | 4 | M | Direct |
Footnotes
- The price in Column 4 is a weighted average price per share. The shares were sold in multiple transasctions at prices ranging from $31.43 per share to $31.55 per share. The reporting person will provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- Vests and becomes exercisable ratably quarterly over four years commencing on April 27, 2009, the grant date